Quick Answer
iBio, Inc. reported Total Assets of $23.18 million for fiscal year 2025.
iBio, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $23.18M | -19.3% |
| 2024 | $28.73M | -30.3% |
| 2023 | $41.21M | -58.5% |
| 2022 | $99.41M | -32.4% |
| 2021 | $146.97M | +56.0% |
| 2020 | $94.19M | +123.1% |
| 2020 | $42.22M | +38.0% |
| 2019 | $30.59M | -29.0% |
| 2018 | $43.08M | +19.6% |
| 2017 | $36.01M | -30.2% |
| 2016 | $51.60M | +313.0% |
| 2015 | $12.49M | +92.4% |
| 2014 | $6.49M | -30.6% |
| 2013 | $9.35M | -4.2% |
| 2012 | $9.77M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $64.39M | +196.8% | +0.4% |
| September 30, 2025 | $64.16M | +161.7% | +176.7% |
| June 30, 2025 | $23.18M | -19.3% | +21.4% |
| March 31, 2025 | $19.10M | -61.9% | -12.0% |
| December 31, 2024 | $21.70M | -36.2% | -11.5% |
| September 30, 2024 | $24.52M | -34.9% | -14.7% |
| June 30, 2024 | $28.73M | -30.3% | -42.7% |
| March 31, 2024 | $50.15M | +13.0% | +47.4% |
- iBio, Inc. showed a decrease of -19.3% in Total Assets compared to the prior fiscal year.
- Over the 2012–2025 period, iBio, Inc.’s total assets has grown by 137.4% (from $9.77 million to $23.18 million).
- The most recent figure is from iBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 5, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: